Follow Home Visits After Discharge

January 9, 2015 updated by: Zealand University Hospital

Follow Home Visits by Hospital and Municipality After Discharge of Frail Elderly Patients From Nykøbing Falster Hospital - a Randomized Controlled Trial

The study aims to assess whether a follow home visit after discharge of frail elderly patients from Nykøbing Falster Hospital reduces the risk of readmission within 180 days.

Staff from the hospital ward identifies patients fulfilling the inclusion criteria and refers the patients to two project nurses at the hospital (follow home team). One of the project nurses gets the informed consent from the patient, or in case of a patient who is not able to give informed consent, from the family and general practitioner. The patient is then randomized to intervention (follow home visit after discharge) or control.

In the intervention group, the hospital project nurse and the patient meets with the municipal nurse in the patient's home on the same day the patient is being discharged from the hospital. During this visit the discharge from the hospital and the actual functioning of the patient in his own surroundings is reviewed, using a structured assessment.

Study Overview

Detailed Description

The study consists of two parts: First, the project nurse reviews the patients hospitalization and discharge together with the nurse from the ward. Next, the patient is discharged from the hospital and is driven by the project nurse from the hospital to the patient's home where they meet the nurse from the municipality. Together with the patient the two nurses review:

  • Cognitive skills
  • Medicine
  • Nutrition
  • Mobility
  • Level of functioning
  • Future appointments in the health care sector

All patients in the project - both patients in the intervention group and patients in the control group - will receive treatment and care equivalent to normal applicable quality standards with discharge from the hospital.

It is expected that the study will demonstrate a reduction of hospital readmissions within 180 days in the intervention group with 14 % (with a power of 90% and a significance level of 5%). There will be a need for 200 patients in both the control and intervention group, ie 400 patients in total.

Study Type

Interventional

Enrollment (Actual)

545

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nykøbing Falster, Denmark
        • Region Zealand, Nykøbing Falster Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Discharge from the Medical Department, Geriatric Department B, Emergency Department, Surgical Department or Department of Orthopedic Surgery at Nykøbing Falster Hospital.

Address in Guldborgsund, Lolland or Vordingborg municipalities.

Minimum 3 out of the following 9 criteria must be met:

  • The patient's behavior raises suspicion of cognitive disorders, including dementia, which affects how the patient masters his daily life.
  • The patient has an abuse of medication, drugs and / or alcohol, which affects how the patient masters his daily life.
  • The patient has a psychiatric disorder that affects how the patient masters his daily life.
  • The patient has a strained - or no - social network.
  • The patient has a significantly lower level of functioning compared to prior to admission.
  • The patient uses 6 or more different types of drugs at the time of discharge.
  • The patient has, within the preceding 6 months, had at least one acute hospital contact beyond the current.
  • The patient has a fall-history where the cause is not yet determined.
  • There are suspicion of housing conditions that hamper the patient in his daily activities.

Exclusion Criteria:

  • Patients who do not want to participate or cannot give informed consent. Discharge between 4 pm and 8 am Monday-Friday and discharge on weekends. Patients with planned readmission. Former participant in the study. Patients who needs terminal care.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Review of follow home visits after discharge from Nykøbing Falster Hospital
The intervention is follow home visits which is randomized and is an intervention that is assigned by the investigator.
No Intervention: Control
Standard health care and discharge services

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The proportion of patients who are readmitted
Time Frame: 180 days
180 days

Secondary Outcome Measures

Outcome Measure
Time Frame
Time to readmission
Time Frame: 180 days
180 days
Total number of readmissions
Time Frame: 180 days
180 days
Total number of days of readmission
Time Frame: 180 days
180 days
The number of contacts with general practitioner
Time Frame: 180 days
180 days
Death
Time Frame: 180 days
180 days
Total use of municipal services (nursing, practical help, personal care)
Time Frame: 180 days
180 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Maurice Antoine Lembeck, MD, Region Zealand, Nykøbing Falster Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (Actual)

December 1, 2014

Study Completion (Actual)

January 1, 2015

Study Registration Dates

First Submitted

December 11, 2014

First Submitted That Met QC Criteria

December 16, 2014

First Posted (Estimate)

December 17, 2014

Study Record Updates

Last Update Posted (Estimate)

January 12, 2015

Last Update Submitted That Met QC Criteria

January 9, 2015

Last Verified

January 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • SJ-329

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe